邢燕
个性化签名
- 姓名:邢燕
- 目前身份:
- 担任导师情况:
- 学位:
-
学术头衔:
- 职称:-
-
学科领域:
临床医学
- 研究兴趣:
邢燕,1999年毕业于山西医科大学儿科系获学士学位,1999~2000年任山西省儿童医院住院医师,2003年获新乡医学院儿科硕士学位,2003~2006年在北京大学第一医院攻读科学学位博士研究生并于2006年获北京大学医学博士学位,现为北京大学第三医院儿科医师、助理研究员。
在北京大学第一医院攻读博士期间师从丁洁教授,所从事的课题主要研究“裂孔隔膜分子及足细胞骨架分子在蛋白尿产生中的作用”(国家自然科学基金项目:301709920),还参与了丁洁教授国家自然科学基金项目“抗蛋白尿药物在足细胞作用的分子机制探讨”(30672259)的前期工作,主要完成了一些抗蛋白尿药物对肾病鼠肾小球足细胞分子的影响,熟练掌握了动物实验、细胞培养、免疫蛋白印迹、免疫沉淀、荧光实时定量PCR、间接免疫荧光染色、免疫组化染色、ELISA等实验技术。研究结果作为毕业论文通过博士学位答辩,且已在国内外发表,尤其在国际权威学术杂志Kidney International(作为共同第一作者)和Experimental Biology and Medicine(第一作者)上发表论著,同时在国内外进行了广泛的学术交流,曾获2007年第十四届国际儿科肾脏病大会最佳壁报交流奖、2005年第九届亚洲儿科肾脏病大会最佳口头交流奖以及2005年全国儿科中青年医师雀巢优秀论文二等奖。
博士毕业后,先后获高等学校博士学科点专项科研基金(基金号:20070001787)和北京大学第三医院科研基金资助。
-
主页访问
3944
-
关注数
1
-
成果阅读
435
-
成果数
10
【期刊论文】Diversities of Podocyte Molecular Changes Induced by Different Antiproteinuria Drugs
邢燕, YAN XING, JIE DING, QINGFENG FAN, ANDNA GUAN
Exp Biol Med 231: 585-593, 2006,-0001,():
-1年11月30日
Nephrin, podocin, CD2AP, and a-actinin-4 are important podocyte proteins that help maintain the integrity of the slit diaphragm and prevent proteinuria. Studies have shown that angiotensin-converting enzyme inhibitors, glucocorticoids, and all-trans retinoic acid (ATRA) have antiproteinuric effects. However, it is still unclear whether these drugs, with different pharmacological mechanisms, lead to a reduction in proteinuria by changing the expression and distribution of these important podocyte proteins. In this study, changes in the expression and distribution of nephrin, podocin, CD2AP, and a-actinin-4 were dynamically detected in Adriamycin-induced nephrotic (ADR) rats treated with three different drugs: lisinopril, prednisone, and ATRA. Nephropathy was induced by an intravenous injection of Adriamycin. After Adriamycin injection, rats received lisinopril, prednisone, and ATRA treatment, respectively. Renal tissues were collected at Days 3, 7, 14, and 28. The distribution and the expression of messenger RNA and protein of nephrin, podocin, CD2AP, and a-actinin-4 were detected by indirect immunofluorescence, real-time polymerase chain reaction, and Western blotting, respectively. With the intervention of lisinopril, prednisone, and ATRA, changes in the expression of nephrin, podocin, and CD2AP were diverse, which was different from that detected in ADR rats. After lisinopril and prednisone intervention, podocin exhibited prominent earlier changes compared with those of nephrin and CD2AP, whereas CD2AP showed more prominent changes after ATRA intervention. There was no change in the expression of a-actinin-4 molecule. In summary, we conclude that the antiproteinuric effects of lisinopril, prednisone, and ATRA were achieved by changes in the expression and distribution of the important podocyte molecules nephrin, podocin, CD2AP, and a-actinin-4. The pattern in the change of podocyte molecules after lisinopril and prednisone intervention was similar, but the pattern in the change of podocyte molecules after ATRA intervention was different from that of lisinopril or prednisone intervention.
nephrin, podocin, CD2AP, a-actinin, antiproteinuria drugs
-
51浏览
-
0点赞
-
0收藏
-
0分享
-
155下载
-
0评论
-
引用
邢燕, HAN Ziming, XING Yan, WANG Hongwei, LIANG Xiuling, ZHOU Jianhua
Journal of Huazhong University of Science and Technology [Med Sci]华中科技大学学报[ 医学(英德文) 版] 24 (3): 254-258, 2004,-0001,():
-1年11月30日
The effects of the combined use of angiotensin converting enzyme inhibitor (ACEI) benazepril and angiotensin Ⅱ type 1 receptor antagonist (AT1RA) valsartan on apoptosis and the expression of apoptosis2related proteins Fas and FasL in the kidney of rats with adriamycin2induced nephritic glomerulosclerosis was investigated. Uninephrectomy and the injection of adriamycin induced the rat model of glomerulosclerosis. Benazepril (6 mg/ kg), valsantan (20 mg/ kg), or benazepril (3 mg/ kg) plus valsantan (20 mg/ kg) was respectively delivered daily by gavage to the rats in three treatment groups for 12 weeks. Apoptosis was examined by means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling ( TUNEL). Immunohistochemistry was adopted to detect the expression of Fas and FasL. Software of pathological analysis quantitated the levels of Fas and FasL. The results showed that as compared with those in the control group, the kidneys in the model group had more severe glomerulosclerosis, much more apoptotic cells and higher levels of expression of Fas and FasL. The degree of glomerulosclerosis, the number of apoptotic cells and the levels of expression of Fas and FasL were reduced by benazepril and valsartan. The combined use of benazepril and valsartan had the best therapeutic effect. It was concluded that benazepril and valsartan could suppress the excessive apoptosis of kidney cells by lowering the expression of the apoptosis-related proteins Fas and FasL, so as to postpone the process of glomerulosclerosis. The combined use of benazepril and valsartan has better therapeutic effect .
benazepril, valsartan, adriamycin nephropathy, apoptosis, Fas, FasL
-
70浏览
-
0点赞
-
0收藏
-
0分享
-
121下载
-
0评论
-
引用
邢燕, Q Fan, Y Xing, J Ding, N Guan and J Zhang
,-0001,():
-1年11月30日
The abnormality of a single podocyte molecule, caused by a single gene mutation, such as NPHS1, NPHS2, CD2AP, and ACTN4, can lead to the hereditary/congenital nephrotic syndromes (NS). Further studies suggested that more than one podocyte molecule were together involved in acquired or experimental NS. However, we do not know much on the relationship among these podocyte molecules, and the molecular response induced by the change of each podocyte protein to the remaining ones. We respectively knockdown the nephrin, podocin, CD2AP, or a-actinin-4 mRNA by using reconstructed RNA interference vector – psiRNA-hH1GFPzeo in mouse podocyte clone. The molecular behavior or response was revealed by the quantitative expression both at mRNA and protein levels with RT-PCR and Western blot, and by the molecular distribution detected with confocal microscopy. With nephrin knockdown, only CD2AP increased, whereas podocin showed no change. Contrarily, with podocin or CD2AP knockdown, nephrin decreased, while CD2AP or podocin increased. Nephrin, podocin, or CD2AP knockdown did not change the expression of a-actinin-4, whereas a-actinin-4 knockdown begetted the reduction of nephrin, and the increment of podocin and CD2AP. The redistributions of nephrin, podocin, and CD2AP were revealed around a predominant nuclear staining compared with the membrane surface staining in the control podocytes. Our data imply that the response between the four podocyte molecules is very complicated and evidently different. There is not always an interaction between podocyte molecules. The normal localization of podocyte molecules would depend on their normal expression quantity and the molecular reactions between them.
RNAi, mouse podocyte clone, nephrin, podocin, CD2AP, a-actinin-4
-
41浏览
-
0点赞
-
0收藏
-
0分享
-
199下载
-
0评论
-
引用
【期刊论文】导致家族性局灶节段性肾小球硬化新基因——TRPC6
邢燕, 范青锋, 综述, 丁洁, 审校
J Nephrol Dialy Transplant, Vol.15, No.2, Apr.2006,-0001,():
-1年11月30日
蛋白尿是肾脏疾病最常见的临床症状之一。近年来,Nephrin、Podocin、CD2AP和α2actinin24等重要足细胞结构蛋白和细胞骨架分子的确立,为肾小球性蛋白尿发生机制的研究提供了新的思路[ 1~5 ] 。然而,由于蛋白尿临床病理以及遗传背景的异质性,其发生机制尤其是分子机制仍未完全阐明。2005年,Winn和Reiser研究组又确定了一个导致家族性局灶节段性肾小球硬化( FSGS ) 的基因——TRPC6[ 6, 7 ] ,其编码蛋白瞬时受体电位阳离子通道蛋白( transient recep tor potential cation channel 6,TRPC6)是一个非选择性阳离子通道,新近发现其在足细胞也有表达,而且和裂孔隔膜分子Nephrin以及Podocin间存在相互作用,这一发现将足细胞结构蛋白和离子通道联系起来,丰富了足细胞分子网络,拓宽了对肾小球性蛋白尿发生机制的认识。因此,认识该基因、筛查可能存在的突变以及进一步研究该基因的功能将对探讨蛋白尿发生的分子机制以及防治蛋白尿具有新的意义。本文着重介绍TRPC6突变致家族性FSGS,同时对TRPC6在肾脏疾病领域的研究也作一概述。
TRPC6, 局灶节段性肾小球硬化
-
68浏览
-
0点赞
-
0收藏
-
0分享
-
146下载
-
0评论
-
引用
邢燕, 丁洁, 范青锋, 管娜, 张敬京
中华肾脏病杂志2006年5月第22卷第5期/Chin J Nephrol, May 2006, Vol 22, No.5,-0001,():
-1年11月30日
目的从足细胞分子的角度探讨抗蛋白尿药物作用的细胞分子机制。方法建立阿霉素肾病大鼠模型。注射阿霉素后次日分别给予利生普利、泼尼松以及全反式维甲酸(ATRA)干预蛋白尿。注射阿霉素后第3、7、14、28天每组处死6只大鼠,留取。肾脏标本。应用间接免疫荧光染色、实时PCR、Western印迹分别检测各个时间点nephrin、podocin、CD2相关蛋白(AP)、α辅肌动蛋白(actinin)-4的分布、mRNA和蛋白表达量的变化。应用免疫沉淀检测nephrin与podocin、nephfin与CD2AP分子间作用以及nephrin磷酸化水平。结果与对照组相比,第14天时肾病组尿蛋白显著增加(P < 0.01)。与肾病组相比,利生普利、泼尼松和ATRA干预后均显著降低了蛋白尿(P < 0.05),减轻了足突融合。通过分析不同时间点足细胞分子的表达.显示3种干预药物均引起了nephrin、podocin、CD2AP表达的变化,维持了正常的nephrin磷酸化水平,而且利生普利和泼尼松首先抑制了podocin分子,而ATRA首先抑制了CD2AP分子的异常变化。与此同时,nephrin、podocin、CD2AP和α-actinin-4分子的分布在干预后也趋于正常。此外.无论在肾病组还是干预组大鼠,nephrin与podocin、nephtin与CD2AP分子间一直保持着共沉淀关系。结论利生普利、泼尼松和ATRA都通过稳定重要的足细胞分子nephrin、podocin、CD2AP来发挥它们的抗蛋白尿作用。
蛋白尿, 肾疾病, 分子作用机制, 药物, 足细胞
-
38浏览
-
0点赞
-
0收藏
-
0分享
-
64下载
-
0评论
-
引用
-
36浏览
-
0点赞
-
0收藏
-
0分享
-
159下载
-
0评论
-
引用
邢燕, 范青锋, 刘淑芳, 张 涵, 丁洁
实用儿科临床杂志第22卷第17期2007年9月/J Appl Clin Pediatr, Vol.22 No.17, Sep.2007,-0001,():
-1年11月30日
目的 探讨瞬时受体电位阳离子通道蛋白6 ( TRPC6)在正常人、小鼠和大鼠肾组织及小鼠足细胞系(MPC5)的表达和分布,为研究TRPC6在肾脏的功能及其与足细胞分子间的关系奠定基础。方法 1. 应用免疫组织化学方法观察TRPC6在正常人、小鼠和大鼠肾组织及MPC5分布。2. 通过反转录酶-聚合酶链反应(RT-PCR)检测TRPC6在小鼠肾组织和MPC5表达。3. 应用免疫蛋白印迹检测TRPC6在正常人、小鼠和MPC5表达。结果 1. TRPC6在正常人肾小球呈弱表达,在肾小管和肾血管表达较强,在小鼠和大鼠主要沿肾小球毛细血管袢和系膜区分布,肾间质也有少许表达。TRPC6在MPC5的荧光染色为阳性,在分化态细胞主要分布于胞膜表面。2. 在小鼠肾组织及MPC5均检测到特异性TRPC6的PCR产物条带。3. 在正常人、小鼠肾组织及MPC5均检测到特异性的相对分子质量为106的TRPC6蛋白条带。结论 TRPC6在正常人、小鼠和大鼠肾小球均有表达,在mRNA及蛋白水平均证实MPC5能表达TRPC6,为从离子通道的角度利用MPC5探讨蛋白尿发生的分子机制奠定基础。
肾脏, 足细胞, 瞬时受体电位阳离子通道蛋白6, 表达, 分布
-
40浏览
-
0点赞
-
0收藏
-
0分享
-
231下载
-
0评论
-
引用
邢燕, Zi-Ming HAN, Yan XING, Hong-Wei WANG, Xiu-Ling LIANG, Jian-Hua ZHOU
中国当代儿科杂志第5卷第4期2003年8月/Chin J Contemp Pediatr Vol.5 No.4 Aug.2003,-0001,():
-1年11月30日
Objective To inquire into the effects of angiotensin Ⅱtype 1 receptor antagonist (AT1RA) valsartan on apoptosis and the expression of apoptosis correlated protein Fas and FasL in the kidneys of rats with nephritic glomerulosclerosis induced by adriamycin. Methods Thirty six SD rats were randomly divided into model group, treatment group and control group. The model was established by uninephrectomy and injection of adriamycin. In the treatment group, valsartan (20 mg/ kg) was delivered daily by gavage for 12 weeks. The same amount of normal saline was delivered by gavage in the control and model groups. Apoptosis was examined by means of terminal-deoxynucleotidyl transferase mediated d-UTP nick end labeling (TUNEL). Glomerular apoptotic index (GAI) and renal tubule apoptotic index (TAI) were calculated. Immunohistochemistry was utilized to detect the expression of Fas and FasL. The morphological changes were observed under optic microscope and the glomerulosclerosis index (GSI) was determined. Results Compared with the control group, the GSI, GAI, TAI and the expression of Fas and FasL in model and treatment groups were stronger (P < 0.01). Compared with model group, they decreased in treatment group (P <0.01). Conclusions Valsartan may suppress the excessive apoptosis of kidney cells by lowering the expression of Fas and FasL so as to postpone the process of glomerulosclerosis.
Angiotensin Ⅱtype 1 receptor antagonist, Valsartan, Adriamycin nephropathy, Apoptosis, Fas, FasL
-
38浏览
-
0点赞
-
0收藏
-
0分享
-
106下载
-
0评论
-
引用
邢燕, 丁洁
中国实用儿科杂志2004年6月第19卷第6期,-0001,():
-1年11月30日
随着医学遗传学和分子遗传学的迅速发展,遗传性肾脏病越来越受到临床重视。许多遗传性肾脏病可有血尿表现,甚至以血尿表现为主,为此我们着重对以血尿为主要表现的单基因遗传性肾脏病作一综述,并对IgA肾病和相关综合征作简单介绍。
-
23浏览
-
0点赞
-
0收藏
-
0分享
-
199下载
-
0评论
-
引用
邢燕, 丁洁, 范青锋, 管娜
中华肾脏病杂志2006年第22卷第1期/Chin J Nephrol, January 2006, Vol.22, No.1 ,-0001,():
-1年11月30日
目的动态观察足细胞裂孔隔膜复合体分子nephrin、podocin、CD2AP及α-actinin-4 在阿霉素肾病大鼠蛋白尿发生发展中的表达变化,探讨其在蛋白尿发生发展中的分子行为及其机制。方法尾静脉注射阿霉素建立阿霉素肾病大鼠模型,3、7、14、28 d每组处死6只大鼠留取肾脏标本。应用间接免疫荧光染色、实时定量PCR、Western印迹分别检测各个时间点 nephrin、podocin、CD2AP、α-actinin-4的分布、mRNA和蛋白表达量的变化。结果 (1)14 d肾病组大鼠24 h尿蛋白显著高于对照组(P<0.01),增高持续到28 d。(2)透射电镜显示14 d肾病组足突不同程度变宽,28 d足突弥漫性融合。(3)与对照组相比,从第7天开始肾病组nephrin和podocin染色从沿肾小球毛细血管袢线样分布向不连续粗颗粒样的分布模式转变;CD2AP节段染色增强区逐渐扩大,有的区域呈斑片状和连续线状增强;α-actinin-4从沿肾小球毛细血管袢均匀的点线样分布向不均匀粗颗粒的分布转变,而且随时间进展这种转变逐渐加重。(4)与对照组相比,肾病组于7 d时nephrin mRNA表达显著增高(P<0.01);podocin mRNA表达14 d时显著增高(P<0.05),直至28 d(P<0.05);CD2AP mRNA表达28 d时显著增高(P<0.05)。(5)与对照组相比,肾病组nephrin蛋白表达28 d时显著增高(P<0.05);podocin蛋白表达于7 d时显著增高(P<0.05),而28 d时又显著降低(P<0.05);CD2AP蛋白表达于14 d时显著增高(P< 0.05),直至28 d(P<0.05)。(6)α-actinin-4 mRNA与蛋白表达在实验过程中未出现明显变化。结论 nephrin、podocin和CD2AP的表达增加及分布异常是导致阿霉素肾病大鼠蛋白尿发生发展的分子机制,而分子表达的增加是足细胞抵抗损伤的一种代偿反应。
蛋白尿, 肾病综合征, 辅肌动蛋白, 足细胞分子
-
30浏览
-
0点赞
-
0收藏
-
0分享
-
82下载
-
0评论
-
引用